Discontinuation of First-Line Bevacizumab in Metastatic Colorectal Cancer: The BEAWARE Italian Observational Study
Tumori - Italy
doi 10.1177/0300891619834126
Full Text
Open PDFAbstract
Available in full text
Date
March 11, 2019
Authors
Publisher
SAGE Publications